Journal of Nanobiotechnology (Mar 2025)

NaHS@Cy5@MS@SP nanoparticles improve rheumatoid arthritis by inactivating the Hedgehog signaling pathway through sustained and targeted release of H2S into the synovium

  • Xue-Xue Zhu,
  • An-Jing Xu,
  • Wei-Wei Cai,
  • Zhi-Jun Han,
  • Shi-Jie Zhang,
  • Bao Hou,
  • Yuan-Yuan Wen,
  • Xing-Yu Cao,
  • Hao-Dong Li,
  • Yue-Qing Du,
  • You-Yi Zhuang,
  • Jing Wang,
  • Xiao-Ran Hu,
  • Xin-Ran Bai,
  • Jia-Bao Su,
  • Ao-Yuan Zhang,
  • Qing-Bo Lu,
  • Ye Gu,
  • Li-Ying Qiu,
  • Lin Pan,
  • Hai-Jian Sun

DOI
https://doi.org/10.1186/s12951-025-03286-1
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 23

Abstract

Read online

Abstract Background Aberrant proliferation and inflammation of fibroblast-like synoviocytes (FLSs) significantly contribute to the pathogenesis of rheumatoid arthritis (RA). Deficiency of hydrogen sulfide (H2S) is a driving force for the development of RA, and the short half-life of the H2S-releasing donor sodium hydrosulfide (NaHS) limits its clinical application in RA therapy. Designing a targeted delivery system with slow-release properties for FLSs could offer novel strategies for treating RA. Methods Herein, we designed a strategy to achieve slow release of H2S targeted to the synovium, which was accomplished by synthesizing NaHS-CY5@mesoporous silic@LNP targeted peptide Dil (NaHS@Cy5@MS@SP) nanoparticles. Results Our results demonstrated that NaHS@Cy5@MS@SP effectively targets FLSs, upregulates H2S and its-producing enzyme cystathionine-γ-lyase (CSE) in the joints of arthritic mice. Overexpression of CSE inhibited the proliferation, migration, and inflammation of FLSs upon lipopolysaccharide (LPS) exposure, effects that were mimicked by NaHS@Cy5@MS@SP. In vivo studies showed that NaHS@Cy5@MS@SP achieved a threefold higher AUCinf than that of free NaHS, significantly improving the bioavailability of NaHS. Further, NaHS@Cy5@MS@SP inhibited synovial hyperplasia and reduced bone and cartilage erosion in the DBA/1J mouse model of collagen-induced arthritis (CIA), which was superior to NaHS. RNA sequencing and molecular studies validated that NaHS@Cy5@MS@SP inactivated the Hedgehog signaling pathway in FLSs, as evidenced by reductions in the protein expression of SHH, SMO, GLI1 and phosphorylated p38/MAPK. Conclusion This study highlights NaHS@Cy5@MS@SP as a promising strategy for the controlled and targeted delivery of H2S to synoviocytes, offering potential for RA management. Graphical Abstract

Keywords